EBS EBITDA
Emergent Biosolutions Inc · EBITDA
EBS EBITDA
Latest reported-$132.30Mperiod ending
EBS Quarterly EBITDA (-$65.10M → -$132.30M)
Quarterly EBITDA
High-resolution chart · PNG
EBS ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -132,300,000 | |
| 47,900,000 | |
| -12,500,000 | |
| 96,200,000 | |
| 21,400,000 | |
| 132,800,000 | |
| 21,700,000 | |
| 98,400,000 | |
| -130,600,000 | |
| 64,300,000 | |
| -12,600,000 | |
| 24,400,000 | |
| 48,900,000 | |
| -103,000,000 | |
| 38,600,000 | |
| -12,500,000 | |
| -30,000,000 | |
| 37,800,000 | |
| 348,600,000 | |
| -1,100,000 | |
| 49,000,000 | |
| 125,200,000 | |
| 287,400,000 | |
| 119,100,000 | |
| 154,600,000 | |
| 17,200,000 | |
| 108,500,000 | |
| 98,400,000 | |
| 21,500,000 | |
| -600,000 | |
| 43,894,000 | |
| 33,700,000 | |
| 79,200,000 | |
| 2,800,000 | |
| 72,215,000 | |
| 58,471,000 | |
| 18,660,000 | |
| 25,476,000 | |
| 66,940,000 | |
| 49,612,000 | |
| 6,888,001 | |
| 30,797,000 | |
| 84,449,000 | |
| 71,720,000 | |
| 48,685,000 | |
| -18,178,000 | |
| 60,887,000 | |
| 40,024,000 | |
| 16,321,000 | |
| -18,211,000 | |
| 36,717,000 | |
| 23,322,000 | |
| 18,921,000 | |
| -9,187,000 | |
| 24,548,000 | |
| 12,587,000 | |
| 12,125,000 | |
| -9,286,000 | |
| 48,191,000 | |
| 3,879,000 | |
| 22,471,000 | |
| -33,237,000 | |
| 36,952,000 | |
| 22,017,000 | |
| 15,187,000 | |
| 4,854,000 | |
| 5,812,000 | |
| -2,349,000 | |
| 24,250,000 | |
| 18,804,000 | |
| 2,271,000 | |
| 15,338,000 | |
| 4,394,000 | |
| 12,907,000 | |
| 44,378,000 | |
| 4,422,000 | |
| -7,523,000 | |
| -4,633,000 | |
| 45,349,000 | |
| 10,198,000 | |
| 21,948,000 | |
| 21,948,000 | |
| -38,989,000 | |
| 28,967,000 | |
| 28,967,000 | |
| 28,967,000 | |
| -49,669,000 | |
| 20,874,000 | |
| 20,874,000 | |
| 20,874,000 | |
| -65,100,000 | |
| -34,700,000 | |
| -292,900,000 | |
| 6,400,000 | |
| -65,100,000 |